Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Takeda UK names new market access director

Takeda UK names new market access director

26th January 2017

Takeda UK has strengthened its senior team with the appointment of Peter Wheatley Price as its new market access director.

Mr Price joins the company from GlaxoSmithKline, where he served as global market access and pricing director, overseeing the successful launch of the company's first respiratory biologic therapy for severe asthma.

In his new role, he will be responsible for ensuring patients and the NHS can benefit as much as possible from Takeda's treatments, taking responsibility for market access, reimbursement and pricing, with a focus on key therapy areas such as irritable bowel disease, diabetes and oncology.

He has been appointed as the successor to Ross Selby, who has relocated to the US to act as Takeda's new head of global pricing, market access and health economics for Oncology products.

Adam Zaeske, managing director of Takeda UK, said: "Owing to our ambitions to continue to deliver improved outcomes both for patients and our customers, I am delighted that we have been able to attract such a strong talent as Peter to take on such an important role."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801831571-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.